Understanding the mechanisms of glutamine action in critically ill patients

Anais da Academia Brasileira de Ciencias

Volumn 82, Issue 2, 2010, Pages 417-430

  Oliveira, Gisele P ^a   Dias, Cristina M ^a   Pelosi, Paolo ^b   Rocco, Patricia R M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Apoptosis; Cytokines; Glutamine; Heat shock protein

Indexed keywords

EID: 77954186450     PISSN: 00013765     EISSN: 16782690     Source Type: Journal    
DOI: 10.1590/s0001-37652010000200018     Document Type: Article

References (81)

1. Abcouwer SF, Bode BP and Souba WW. 1995. Glucocorticoids regulate rat glutamine synthetase expression in a tissue-specific manner. J Surg Res 59: 59-65.
2. Andreasen AS, Pedersen-Skovsgaard T, Morten-sen OH, Van Hall G, Moseley PL and Pedersen BK. 2009. The effect of glutamine infusion on the inflammatory response and HSP70 during human experimental endotoxemia. Crit Care 13: R7.
3. Asea A, Kraeft SK, Kurt-Jones EA, Stevenson MA, Chen LB, Finberg RW, Koo GC and Calderwood SK. 2000. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med 6: 435-442.
4. Belmonte L et al. 2007. Effects of glutamine supplementation on gut barrier, glutathione content and acute phase response in malnourished rats during inflammatory shock. World J Gastroenterol 13: 2833-2840.
5. Boelens PG, Houdijk AP, Fonk JC, Nijveldt RJ, Ferwerda CC, Von Blomberg-Van Der Flier BM, Thijs LG, Haarman HJ, Puyana JC and Van Leeuwen PA. 2002. Glutamine-enriched enteral nutrition increases HLA-DR expression on monocytes of trauma patients. J Nutr 132: 2580-2586.
6. Boza JJ, Moennoz D, Bournot CE, Blum S, Zbinden I, Finot PA and Ballevre O. 2000. Role of glutamine on the de novo purine nucleotide synthesis in Caco-2 cells. Eur J Nutr 39: 38-46.
7. Buttrose M, McKellar D and Welbourne TC. 1987. Gut-liver interaction in glutamine homeostasis: portal ammonia role in uptake and metabolism. Am J Physiol 252: E746-750.
8. Campisi J, Leem TH and Fleshner M. 2003. Stress-induced extracellular HSP72 is a functionally significant danger signal to the immune system. Cell Stress chaperones 8: 272-286.
9. Camps M, Nichols A and Arkinstall S. 2000. Dual specificity phosphatases: a gene family for control of MAP kinase function. FASEB J 14: 6-16.
10. Chang WK, Yang KD and Shaio MF. 1999. Lymphocyte proliferation modulated by glutamine: involved in the endogenous redox reaction. Clin Exp Immunol 117: 482-488.
11. Chang WK, Yang Kd, Chuang H, Jan JT and Shaio MF. 2002. Glutamine protects activated human T cells from apoptosis by up-regulating glutathione and Bcl-2 levels. Clin Immunol 104: 151-160.
12. Darmaun D, Matthews DE and Bier DM. 1986. Glutamine and glutamate kinetics in humans. Am J Physiol 251: E117-126.
13. Déchelotte P et al. 2006. L-alanyl-L-glutamine dipep-tide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: the French controlled, randomized, double-blind, multicenter study. Crit Care Med 34: 598-604.
14. Ding LA and Li JS. 2003. Effects of glutamine on intestinal permeability and bacterial translocation in TPN-rats with endotoxemia. World J Gastroenterol 9: 1327-1332.
15. DorukN, Buyukakilli B, Atici S, Cinel L, Tamer L, Avlan D, Bilgin E and Oral U. 2005. The effect of preventive use of alanyl-glutamine on diaphragm muscle function in cecal ligation and puncture-induced sepsis model. JPEN J Parenter Enteral Nutr 29: 36-43.
16. Elgadi KM, Labow BI, Abcouwer SF and Souba WW. 1998. Sepsis increases lung glutamine synthetase expression in the tumor-bearing host. J Surg Res 78: 1822.
17. Eliasen MM, Brabec M, Gerner C, Pollheimer J, Auer H, Zellner M, Weingartmann G, Garo F, Roth E and Oehler R. 2006. Reduced stress tolerance of glutamine-deprived human monocytic cells is associated with selective down-regulation of HSP 70 byde-creased mRNA stability. J Mol Med 84: 147-158.
18. Estívariz CF et al. 2008. Efficacy of parenteral nutrition supplemented with glutamine dipeptide to decrease hospital infectious in critically ill surgical patients. JPEN J Parenter Enteral Nutr 32: 389-402.
19. Fleshner M, Campisi J, Amiri L and Diamond DM. 2004. Cat exposure induces both intra- and extra-cellular HSP72: the role of adrenal hormones. Psychoneuroen-docrinology 29: 1142-1152.
20. Fuentes-Orozco C, Cervantes-Guevara G, Muci-ño-Hernández I, López-Ortega A, Ambriz-Gon-zález G, Gutiérrez -de -l a- Rosa JL, Gómez-Herrera E, Hermosillo-Sandoval JM and Gonzá-lez-Ojeda A. 2008. L-alanyl-L-glutamine-supplement-ed parenteral nutrition decreases infectious morbidity rate in patients with severe acute pancreatitis. JPEN J Parenter Enteral Nutr 32: 403-411.
21. Gamrin L, Essén P, Forsberg AM, Hultman E and Wernerman J. 1996. A descriptive study of skeletal muscle metabolism in critically ill patients: free amino acids, energy-rich phosphates, protein, nucleic acids, fat, ater, and electrolytes. Crit Care ed 24: 575-583.
22. Ganter MT, Ware LB, Howard M, Roux J, Gartland B, Matthay MA, Fleshner M and Pittet JF. 2006. Extracellular heat shock protein 2 is a marker of the stress protein response in acute lung injury. Am J Physiol Lung Cell Mol Physiol 291: L354-361.
23. Garrel D, Patenaude J, Nedelec B, Samson L, Dorais J, Champoux J, D'Elia M and Bernier J. 2003. Decreased mortality and infectious morbidity in adult burn patients given enteral glutamine supplements: a prospective, controlled, randomized clinical trial. Crit Care Med 31: 2444-2449.
24. Goeters C, Wenn A, Mertes N, Wempe C, Van AH, Stehle P and Bone HG. 2002. Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients. Crit Care Med 30: 2032-2037.
25. Griffiths RD, Jones C and Palmer TE. 1997. Six-month of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition 13: 295-302.
26. Grover Z, Tubman R and McGuire W. 2007. Glutamine supplementation for young infants with severe gastrointestinal disease. Cochrane Database Syst Rev 24: CD005947.
27. Hall JC, Dobb G, Hall J, De Souza R, Brennan L and McCauley R. 2003. A prospective randomized trial of enteral glutamine in critical illness. Intensive Care Med 29: 1710-1716.
28. Heyland DK, Dhaliwal R, Drover JW, Gramlich L and Dodek P. 2003. Canadian Critical Care Clinical Practice Guidelines Committee. Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. JPEN J Parenter Enteral Nutr 27: 355-373.
29. Heyland DK, Dhaliwal R, Day AG, Muscedere J, Drover J, Suchner U and Cook D. 2006. Canadian Critical Care Trials Group. Reducing deaths due to oxidative stress (The REDOXS Study): Rationale and study design for a randomized trial of glutamine and antioxidant supplementation in critically-ill patients. Proc Nutr Soc 65: 250-263.
30. Huang L, Mivechi NF and Moskophidis D. 2001. Insights into regulation and function of the major stress-induced hsp70 molecular chaperone in vivo: analysis of mice with targeted gene disruption of the hsp70.1 or hsp-70.3. Mol Cell Biol 21: 8575-8591.
31. Humbert B, Nguyen P, Martin L, Dumon H, Val-lette G, Maugère P and Darmaun D. 2007. Effect of glutamine on glutathione kinetics in vivo in dogs. J Nutr Biochem 18: 10-16.
32. Juang P, Fish DN, Jung R and MacLaren R. 2007. Enteral glutamine supplementation in critically ill patients with burn injuries: a retrospective case-control evaluation. Pharmacotherapy 27: 11-19.
33. Karinch AM, Pan M, Lin CM, Strange R and Souba WW. 2001. Glutamine metabolism in sepsis and infection. J Nutr 131(Suppl 9): 2535S-2538S.
34. Ko YG, Kim EY, Kim T, Park H, Park HS, Choi EJ and Kim S. 2001. Glutamine-dependent antiapoptotic interaction of human glutaminyl-t RNA synthetase with apoptosis signal-regulating kinase 1. J Biol Chem 276: 6030-6036.
35. Kreymann KG. 2006. German Society for Nutritional Medicine and European Society for Parenteral and Enteral Nutrition. ESPEN Guidelines on Enteral Nutrition: Intensive care. Clin Nutr 25: 210-223.
36. Labow BI, Abcouwer SF, Lin CM and Souba WW. 1998. Glutamine synthetase expression in the rat lung is regulated by protein stability. Am J Physiol 275: l877-1886.
37. Labow BI, Souba WW and Abcouver SF. 1999. Glutamine synthetase expression in muscle is regulated by transcriptional and posttranscriptional mechanisms. Am J Physiol276: 1136-1145.
38. Labow BI, Souba WW and Abcouwer SF. 2001. Mechanisms governing the expression of the enzymes of glutamine metabolism - Glutaminase and Glutaminase Syn-thetase. J Nutr 131: 2467S-2474S.
39. Lewis MI, Bodine SC, Kamagar N, Xu X, Da X and Fournier M. 2006. Effect of severe short-term malnutrition on diaphragm muscle signal transduction pathways influencing protein turnover. J Appl Physiol 100: 1799-1806.
40. Mezzarobba V, Torrent A, Leydier I, Alles S, Bra-jon B, Mignon M, Attaix D and Meynial-Denis D. 2003. The role of adrenal hormones in the response of glutamine synthetase to fasting in adult and old rats. Clin Nutr 22: 569-575.
41. Morrison AL, Dinges M, Singleton KD, Odoms K, Wong HR and Wischmeyer PE. 2006. Glutamine's protection against cellular injury is dependent on heat shock factor-1. Am J Physiol Cell Physiol 290: C1625-1632.
42. Newsholme P, Curi R, Gordon S and Newsholme EA. 1986. Metabolism of glucose, glutamine, long-chain fatty acids and ketone bodies by murine macrophages. Biochem J 239: 121-125.
43. Novak F, Heyland DK, Avenell A, Drover JW and Su X. 2002. Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med 30: 2022-2029.
44. Oba M, Baldwin RL and Bequette B J. 2004. Oxidation of glucose, glutamate, and glutamine by isolated ovine enterocytes in vitro is decreased by the presence of other metabolic fuels. J Anim Sci 82: 479-486.
45. Oehler R, Pusch E, Zellner M, Dungel P, Hergov-ics N, Homoncik M, Eliasen MM, Brabec M and Roth E. 2001. Cell type-specific variations in the induction of hsp70 in human leukocytes by fever like whole body hyperthermia. Cell Stress and Chaperones 6: 306-315.
46. Oehler R, Pusch E, Dungel P, Zellner M, Eliasen MM, Brabec M and Roth E. 2002. Glutamine depletion impairs cellular stress response in human leucocytes. Br J Nutr 87(Suppl): S17-21.
47. O'LearyMJ, XueA, Scarlett CJ, Sevette A, Kee AJ and Smith RC. 2007. Parenteral versus enteral nutrition: effect on serum cytokines and the hepatic expression of mRNA of suppressor of cytokine signaling proteins, insulin-like growth factor-1 and the growth hormone receptor in rodent sepsis. Crit Care 11: R79.
48. Oudemans-van Straaten HM, Bosman RJ, Treskes M, Van Der Spoel HJ and Zandstra DF. 2001. Plasma depletion and patient outcome in acute ICU admissions. Intensive Care Med 27: 84-90.
49. Parry-Billings M, Evans J, Calder PC and New-sholme EA. 1990. Does glutamine contribute to immunosuppression after major burns? Lancet 336: 523-25.
50. Peng ZY, Hamiel CR, Banerjee A, Wischmeyer PE, Friese RS and Wischmeyer P. 2006. Glutamine attenuation of cell death and inducible nitric oxide synthase expression following inflammatory cytokine-induced injury is dependent on heat shock factor-1 expression. JPEN J Parenter Enteral Nutr 30: 400-406.
51. PHUA J ET AL. 2009. Has mortality from acute respiratory distress syndrome decreased over time? A systematic review. Am J Respir Crit Care Med 179: 220-227.
52. PIRKKALA L, NYKANEN P AND SlSTONEN L. 2001. Roles of the heat shock transcription factors in regulation of the heat shock response and beyond. FASEB J 15: 1118-1131.
53. Planas M, Schwartz S, Arbos MA and Farriol M. 1993. Plasma glutamine levels in septic patients. JPEN J Parenter Enteral Nutr 17: 299-300.
54. ROPELESKI MJ, RIEHM J, BAER KA, MUSCH Mw AND CHANG EB. 2005. Anti-apoptotic effects of L-Gluta-mine-mediated transcriptional modulation of the heat shock protein 72 during heat shock. Gastroenterology 129: 170-184.
55. ROTH E, FUNOVICS J, MUHLBACHER F, SCHEMPER M, MAURITZ W AND FRITSCH A. 1982. Metabolic disorders in severe abdominal sepsis: Glutamine deficiency in skeletal muscle. Clin Nutr 1: 25-41.
56. ROTH E, Oehler R, Manhart N, Exner R, Wessner B, STRASSER E AND SPITTLER A. 2002. Regulative potential of glutamine-relation to glutathione metabolism. Nutrition 18: 217-221.
57. SAKIYAMA T, MUSCH MW, ROPELESKI MJ, TSUBOUCHI H AND CHANG EB. 2009. Glutamine increases autophagy under Basal and stressed conditions in intestinal epithelial cells. Gastroenterology 136: 924-932.
58. SCHULMAN AS ET AL. 2005. Does the addition of glutamine to enteral feeds affect patient mortality? Crit Care Med 33: 2501-2506.
59. SCHULMAN AS ET AL. 2006. Does enteral glutamine supplementation decrease infectious morbidity? Surg Infect (Larchmt) 7: 29-35.
60. Singleton KD and Wischmeyer PE. 2007. Glutamine's protection against sepsis and lung injury is dependent on heat shock protein 70 expression. Am J Physiol Regul Integr Comp Physiol 292: R1839-1845.
61. SINGLETON KD AND WISCHMEYER PE. 2008. Glutamine induces heat shock protein expression via O-glycosylation and phosphorylation of HSF-1 and Sp1. JPEN J Parenter Enteral Nutr 32: 371-376.
62. SINGLETON KD, BECKEY VE AND WISCHMEYER PE. 2005a. Glutamine prevents activation of NF-kB and stress kinase pathways, attenuates inflammatory cytokine release, and prevents acute respiratory distress syndrome (ARDS) following sepsis. Shock 24: 583-589.
63. Singleton KD, Serkova N, Beckey VE and Wisch-meyer PE. 2005b. Glutamine attenuates lung injury and improves survival after sepsis: Role of enhanced heat shock protein expression. Crit Care Med 33: 1206-1213.
64. Singleton KD, Serkova N, Banerjee A, Meng x, Gamboni-Robertson F and Wischmeyer PE. 2005c. Glutamine attenuates endotoxin-induced lung metabolic dysfunction: potential role of enhanced heat shock protein 70. Nutrition 21: 214-223.
65. Tang ZF, Ling YB, Lin N, Hao Z and Xu RY. 2007. Glutamine recombinant human growth hormone protects intestinal barrier function following portal hypertension surgery. World J Gastroenterol 13: 2223-2228.
66. Tennila A, Salmi T, Pettila V, Roine RO, Varpula T and Takkunen O. 2000. Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis. Intensive Care Med 26: 1360-1363.
67. Tjäder I, Rooyackers O, Forsberg AM, Vesali RF, Garlick PJ and Wernerman J. 2004. Effects on skeletal muscle of intravenous glutamine supplementation to ICU patients. Intensive Care Med 30: 266-275.
68. Tubman TR, Thompson SW and McGuire W. 2005. Glutamine supplementation to prevent morbidity and mortality in preterm infants. Cochrane Database Syst Rev 25: CD001457.
69. Van Der Hulst RR, Von Meyenfeldt MF, Van Kreel BK, Thunnissen FB, Brummer R, Arends JW and Soeters PB. 1998. Gut permeability, intestinal morphology, and nutritional depletion. Nutrition 14: 1-6.
70. Vesali RF, Klaude M, Rooyackers OE, Tjader I, Barle H and Wernerman J. 2002. Longitudinal pattern of glutamine/glutamate balance across the leg in long-stay intensive care unit patients. Clin Nutr 21: 505-514.
71. Weiss YG, Bromberg Z, Raj N, Raphael J, Goloubinoff P, Ben-Neriah Y and Deustchman CS. 2007. Enhanced heat shock protein 70 expression alters proteasomal degradation of IkappaB kinase in experimental acute respiratory distress syndrome. Crit Care Med 35: 2128-2138.
72. Wernerman J, Luo JL and Hammarqvist F. 1999. Glutathione status in critically-ill patients: possibility of odulation by antioxidants. Proc utr Soc 58: 677-680.
73. Wischmeyer PE, Lynch J, Liedel J, Wolfson R, Riehm J, Gottlieb L and Kahana M. 2001. Glutamine administration reduces Gram-negative bacteremia in severely burned patients: A prospective, randomized, double-blind trial versus isonitrogenous control. Crit Care Med 29: 2075-2080.
74. Wright BH, Corton JM, El-Nahas AM, Wood RF and Pockley AG. 2000. Elevated levels of circulanting heat shock protein 70 (HSP70) in peripheral and renal vascular disease. Heart Vessels 15: 18-22.
75. Wu BJ, Kingston RE and Morimoto RI. 1986. Human HSP70 promoter contains at least two distinct regulatory domains. Proc Natl Acad Sci USA 83: 629-633.
76. Yeh CL, Hsu CS, Yeh SL and Chen WJ. 2005. Dietary glutamine supplementation modulates Th1/Th2 cytokine and interleukin-6 expressions in septic mice. Cytokine 31: 329-334.
77. Zheng YM, Li F, Zhang MM and Wu XT. 2006. Glutamine dipeptide for parenteral nutrition in abdominal surgery: a meta-analysis of randomized controlled trials. World J Gastroenterol 12: 7537-7541.
78. Zheng YM, Li F, Qi B, Luo B, Sun H, Liu S and Wu X. 2007. Application of perioperative immunonutrition for gastrointestinal surgery: a meta-analysis of randomized controlled trials. Asia Pac J Clin Nutr 16 Suppl 1: 253257.
79. Ziegler TR, Smith RJ, O'Dwyer ST, Demling RH and Wilmore DW. 1988. Increased intestinal permeability associated with infection in burn patients. Arch Surg 123: 1313-1319.
80. Ziegler TR, Ogden LG, Singleton KD, Luo M, Fernandez-Estivariz C, Griffith DP, Galloway JR and Wischmeyer PE. 2005. Parenteral glutamine increases serum heat shock protein 70 in critically ill patients. Intensive Care Med 31: 1079-1086.
81. Zingarelli B, Sheehan M and Wong HR. 2003. Nuclear factor-kappa B as a therapeutic target in critical care medicine. Crit Care Med 31: S105-S111.